Fresenius SE & Co. KGaA (ETR:FRE)
46.07
+0.50 (1.10%)
Aug 14, 2025, 5:35 PM CET
Fresenius SE & Co. KGaA Revenue
Fresenius SE & Co. KGaA had revenue of 5.58B EUR in the quarter ending June 30, 2025, with 2.59% growth. This brings the company's revenue in the last twelve months to 22.28B, up 4.32% year-over-year. In the year 2024, Fresenius SE & Co. KGaA had annual revenue of 21.83B with 3.64% growth.
Revenue (ttm)
22.28B
Revenue Growth
+4.32%
P/S Ratio
1.15
Revenue / Employee
126.41K
Employees
176,486
Market Cap
25.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.83B | 766.00M | 3.64% |
Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
SCHOTT Pharma AG & Co. KGaA | 972.81M |
Fresenius SE & Co. KGaA News
- 5 days ago - Fresenius SE & Co. KGaA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 days ago - Fresenius SE & Co. KGaA (FSNUF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Our U.S. investment has protected us - Fresenius CEO - CNBC
- 8 days ago - Fresenius Lifts Full-Year Sales Outlook as Revamp Gains Momentum - Financial Post
- 5 weeks ago - EQS-PVR: Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 2 months ago - Fresenius: Healthy Portfolio Add - Seeking Alpha
- 3 months ago - Fresenius medical care outlines 2025 operating income growth targets amid strategic transformations - Seeking Alpha
- 3 months ago - Fresenius SE & Co. KGaA 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha